Caplin Point Laboratories Adjusts Evaluation Score Amid Mixed Technical Indicators and Strong Financial Performance
Caplin Point Laboratories has recently adjusted its evaluation score, reflecting a change in technical trends. The company's financial performance remains strong, with net sales of Rs 502.45 crore and a profit after tax of Rs 142.57 crore. Institutional investor participation has also increased, indicating positive market interest.
Caplin Point Laboratories, a midcap player in the Pharmaceuticals & Biotechnology sector, has recently undergone an adjustment in its evaluation score. This revision reflects a shift in technical trends, moving from a mildly bearish outlook to a sideways position. The company's technical indicators present a mixed picture. The MACD shows a bullish trend on a weekly basis, while the monthly perspective leans mildly bearish. The Relative Strength Index (RSI) indicates no significant signals for both weekly and monthly periods. Bollinger Bands suggest a bullish stance weekly and mildly bullish monthly, while moving averages indicate a mildly bearish trend on a daily basis.
In terms of financial performance, Caplin Point Laboratories reported a robust quarter with net sales reaching Rs 502.45 crore and a profit after tax of Rs 142.57 crore. The company has maintained a strong management efficiency, evidenced by a high return on equity of 19.84% and a low debt-to-equity ratio. Additionally, institutional investors have shown increased participation, raising their stake by 0.77% in the last quarter.
Overall, Caplin Point Laboratories continues to demonstrate significant market performance, with a notable return of 43.23% over the past year, outpacing broader market indices.
Discover the Latest Mojo Score and Financial Trend Performance - SignUp in less than 2 Minutes and get FREE Premium Access.
{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)
{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)
Related Stock Links
- {{stockdata.stock.stock_name.value}} Analysis
- {{stockdata.stock.stock_name.value}} Technicals
- {{stockdata.stock.stock_name.value}} Quality
- {{stockdata.stock.stock_name.value}} Valuation
- {{stockdata.stock.stock_name.value}} Financial Trend
- {{stockdata.stock.stock_name.value}} Return Analysis
- {{stockdata.stock.stock_name.value}} Price Analysis
- {{stockdata.stock.stock_name.value}} Quarterly Result Analysis
- {{stockdata.stock.stock_name.value}} Half-Yearly Result Analysis
- {{stockdata.stock.stock_name.value}} Nine Monthly Result Analysis
- {{stockdata.stock.stock_name.value}} Annual Results
- {{stockdata.stock.stock_name.value}} Balance Sheet
- {{stockdata.stock.stock_name.value}} Profit & Loss
- {{stockdata.stock.stock_name.value}} Cash Flow
- {{stockdata.stock.stock_name.value}} News
- {{stockdata.stock.stock_name.value}} Announcements
- {{stockdata.stock.stock_name.value}} Share Holding
- {{stockdata.stock.stock_name.value}} Peer Comparison
Our weekly and monthly stock recommendations are here
Loading...
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Target Price
{{sm.target_price }}
({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
₹{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
Most Read
